Salas, Sébastien <br/><br/>
Therapeutic drug monitoring for dose individualization of Cisplatin in testicular cancer patients based upon total platinum measurement in plasma.  [electronic resource] 

 -  Therapeutic drug monitoring  Aug 2006 
 - 532-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0163-4356 
<br/><br/><label>Standard No.: </label>10.1097/00007691-200608000-00008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Algorithms<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bayes Theorem<br/>Body Surface Area<br/>Cisplatin--blood<br/>Digestive System Diseases--chemically induced<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Drug Monitoring--methods<br/>Humans<br/>Infusion Pumps<br/>Kidney--drug effects<br/>Kidney Function Tests<br/>Leydig Cell Tumor--blood<br/>Male<br/>Metabolic Clearance Rate<br/>Middle Aged<br/>Models, Statistical<br/>Retrospective Studies<br/>Survival Analysis<br/>Testicular Neoplasms--blood